Phase 2 Relapsed Large B-cell Lymphoma Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
TICAROS Co., Ltd.98 enrolled1 locationNCT07473167
Recruiting
Phase 2
Outpatient Epcoritamab as 2L in NTE R/R DLBCL
Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
Massachusetts General Hospital30 enrolled2 locationsNCT06811272
Recruiting
Phase 1Phase 2
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
Curocell Inc.91 enrolled1 locationNCT04836507